A23K50/50

Composition for preventing or treating muscle weakness-related diseases comprising sobrerol

The present invention relates to sobrerol or a pharmaceutically acceptable salt thereof, which can promote differentiation of myoblasts to form myotubes, thereby preventing muscle weakness and effectively improving muscle functions. Therefore, the pharmaceutical composition containing the same can be effectively used for preventing or treating muscle weakness related diseases.

Concentrated protein compositions and methods of their making and use

This disclosure provides a highly concentrated protein composition and the processes of making the same. The compositions are shelf-stable, easy to use and have excellent nutritional values as compared to other protein products. The compositions may be prepared from animal sources, such as chickens or turkeys.

Concentrated protein compositions and methods of their making and use

This disclosure provides a highly concentrated protein composition and the processes of making the same. The compositions are shelf-stable, easy to use and have excellent nutritional values as compared to other protein products. The compositions may be prepared from animal sources, such as chickens or turkeys.

Non-medicinal food additive for animals, supplemented food containing same and method for improving animal growth
10729158 · 2020-08-04 · ·

This invention relates to a non-medical food additive that is an animal growth promoter containing 99% pure zeolite partially or totally exchanged with a C.sup.m+ cation (in other words a synthetic zeolite) with the general formula I below: 1 m yC m + ( 1 - y ) 1 n M n + AlO 2 x SiO 2 in which x is greater than 1 and advantageously between 1 and 15; M.sup.n+ represents an alkaline or alkaline earth exchangeable ion, advantageously Na.sup.+, K.sup.+, Ca.sup.2+ or Li.sup.+; n is between 1 and 2; y is the exchange rate and is between 0.001 and 1; C.sup.m+ is a metallic cation chosen from among copper Cu.sup.2+, silver Ag.sup.+ or zinc Zn.sup.2+; m is between 1 and 2. It also relates to an additive premix and a supplemented food containing it and a method of improving the growth of animals.

Non-medicinal food additive for animals, supplemented food containing same and method for improving animal growth
10729158 · 2020-08-04 · ·

This invention relates to a non-medical food additive that is an animal growth promoter containing 99% pure zeolite partially or totally exchanged with a C.sup.m+ cation (in other words a synthetic zeolite) with the general formula I below: 1 m yC m + ( 1 - y ) 1 n M n + AlO 2 x SiO 2 in which x is greater than 1 and advantageously between 1 and 15; M.sup.n+ represents an alkaline or alkaline earth exchangeable ion, advantageously Na.sup.+, K.sup.+, Ca.sup.2+ or Li.sup.+; n is between 1 and 2; y is the exchange rate and is between 0.001 and 1; C.sup.m+ is a metallic cation chosen from among copper Cu.sup.2+, silver Ag.sup.+ or zinc Zn.sup.2+; m is between 1 and 2. It also relates to an additive premix and a supplemented food containing it and a method of improving the growth of animals.

Rodenticide binding system
10729127 · 2020-08-04 · ·

In some embodiments, a composition and/or method may include a rodenticide binding system formulated for safe and effective mixture into various feed rations which are fed to monogastric and ruminant animals such as poultry, swine, cows, cattle, and fish, among others. The rodenticide binding system includes novel combinations of one or more of an organoclay, an activated hydrated sodium calcium aluminosilicate clay, and a synthetic hectorite clay. In some embodiments, the binding composition may include organoclay, bentonite, hectorite, Leonardite, and/or any combination thereof. The toxin binding complex may effectively bind some pesticides (e.g., rodenticides) in the animal's digestive system, preventing their absorption and the consequent damages to the animal.

Rodenticide binding system
10729127 · 2020-08-04 · ·

In some embodiments, a composition and/or method may include a rodenticide binding system formulated for safe and effective mixture into various feed rations which are fed to monogastric and ruminant animals such as poultry, swine, cows, cattle, and fish, among others. The rodenticide binding system includes novel combinations of one or more of an organoclay, an activated hydrated sodium calcium aluminosilicate clay, and a synthetic hectorite clay. In some embodiments, the binding composition may include organoclay, bentonite, hectorite, Leonardite, and/or any combination thereof. The toxin binding complex may effectively bind some pesticides (e.g., rodenticides) in the animal's digestive system, preventing their absorption and the consequent damages to the animal.

NITRITE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS
20200237808 · 2020-07-30 ·

Compositions comprising from about 40 weight parts to about 1000 weight parts of a botanical nitrate source; from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity; and from about 4 weight parts to about 100 weight parts of a nitrite salt. Use of said composition in methods of reducing triglycerides or reducing C-reactive protein levels are also provided.

NITRITE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS
20200237808 · 2020-07-30 ·

Compositions comprising from about 40 weight parts to about 1000 weight parts of a botanical nitrate source; from about 20 weight parts to about 500 weight parts of a botanical source of nitrite reduction activity; and from about 4 weight parts to about 100 weight parts of a nitrite salt. Use of said composition in methods of reducing triglycerides or reducing C-reactive protein levels are also provided.

Application of Bacteroides Cellulosityticus in Preparing a Preparation for Preventing and/or Treating Lipid Metabolism Related Diseases

The present invention discloses an application of Bacteroides cellulosilyticus in preparing a preparation for preventing and/or treating lipid metabolism related diseases, such as atherosclerosis related diseases, cardiovascular diseases and obesity.